Matthew Harrison
Stock Analyst at Morgan Stanley
(3.48)
# 929
Out of 5,090 analysts
709
Total ratings
48.96%
Success rate
4.33%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $904.74 | +22.69% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $27.26 | +50.40% | 16 | Dec 4, 2025 | |
| REGN Regeneron Pharmaceuticals | Downgrades: Equal-Weight | $767 | $728.47 | +5.29% | 57 | Dec 3, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $1.41 | +183.69% | 5 | Nov 12, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $104 → $98 | $53.20 | +84.21% | 23 | Oct 28, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $144 → $149 | $181.85 | -18.06% | 55 | Oct 10, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $31 → $32 | $26.21 | +22.09% | 26 | Oct 10, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $20.19 | +48.59% | 13 | Aug 18, 2025 | |
| INSM Insmed | Downgrades: Equal-Weight | $112 → $126 | $204.83 | -38.49% | 19 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $27.66 | +200.07% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.72 | +453.02% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $458.76 | -4.31% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $22.52 | -11.19% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $183.49 | +17.17% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $121.51 | +11.11% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.11 | +92.93% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $1.38 | +262.32% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $140.58 | +26.62% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $31.62 | +77.10% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $27.83 | +97.66% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.21 | +147.93% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $29.64 | -62.88% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.45 | +185.71% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $31.79 | +0.66% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.84 | +394.79% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $2.23 | -55.16% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $20.73 | -51.76% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $9.24 | -13.42% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $31.92 | +37.84% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $5.10 | +154.90% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $25.19 | +217.59% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.28 | +1,036.36% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $95.85 | +125.35% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.42 | +46.20% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.04 | +145.10% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $225.66 | -19.35% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $24.60 | -63.41% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $54.51 | -26.61% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $333.47 | -15.43% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $462.50 | -54.59% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $25.75 | +101.98% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $201.34 | -14.08% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $36.67 | +227.24% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $9.42 | +1,471.13% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $100.61 | -18.50% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $52.21 | +26.41% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $5.19 | +651.45% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $39.07 | +17.74% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $7.17 | +388.15% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,014.30 | -72.89% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.74 | +594.70% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $13.06 | +374.73% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.00 | +1.47% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $100.63 | -17.52% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $65.90 | -84.83% | 4 | Sep 10, 2018 |
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $904.74
Upside: +22.69%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $27.26
Upside: +50.40%
Regeneron Pharmaceuticals
Dec 3, 2025
Downgrades: Equal-Weight
Price Target: $767
Current: $728.47
Upside: +5.29%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $1.41
Upside: +183.69%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $53.20
Upside: +84.21%
Biogen
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $144 → $149
Current: $181.85
Upside: -18.06%
Moderna
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $31 → $32
Current: $26.21
Upside: +22.09%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $20.19
Upside: +48.59%
Insmed
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $204.83
Upside: -38.49%
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $27.66
Upside: +200.07%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.72
Upside: +453.02%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $458.76
Upside: -4.31%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $22.52
Upside: -11.19%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $183.49
Upside: +17.17%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $121.51
Upside: +11.11%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.11
Upside: +92.93%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $1.38
Upside: +262.32%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $140.58
Upside: +26.62%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $31.62
Upside: +77.10%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $27.83
Upside: +97.66%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.21
Upside: +147.93%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $29.64
Upside: -62.88%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.45
Upside: +185.71%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $31.79
Upside: +0.66%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.84
Upside: +394.79%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.23
Upside: -55.16%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $20.73
Upside: -51.76%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $9.24
Upside: -13.42%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $31.92
Upside: +37.84%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $5.10
Upside: +154.90%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $25.19
Upside: +217.59%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.28
Upside: +1,036.36%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $95.85
Upside: +125.35%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.42
Upside: +46.20%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.04
Upside: +145.10%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $225.66
Upside: -19.35%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $24.60
Upside: -63.41%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $54.51
Upside: -26.61%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $333.47
Upside: -15.43%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $462.50
Upside: -54.59%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $25.75
Upside: +101.98%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $201.34
Upside: -14.08%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $36.67
Upside: +227.24%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $9.42
Upside: +1,471.13%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $100.61
Upside: -18.50%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $52.21
Upside: +26.41%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $5.19
Upside: +651.45%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $39.07
Upside: +17.74%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $7.17
Upside: +388.15%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,014.30
Upside: -72.89%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.74
Upside: +594.70%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $13.06
Upside: +374.73%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.00
Upside: +1.47%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $100.63
Upside: -17.52%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $65.90
Upside: -84.83%